Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers – follicular lymphoma and marginal zone lymphoma.
University of Miami Miller School of Medicine Dec 9 2024 Two clinical trial s testing the antibody loncastuximab tesirine showed encouraging results in patients with high-risk forms of two blood cancers – follicular lymphoma and marginal zone lymphoma. The findings, led by physician-scientists at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine , will be presented at the American Society of Hematology 's 2024 meeting in San Diego.
Overcoming high-risk factors Although these types of lymphoma are both typically indolent or slow-growing, patients with either type can see faster progression of their cancer and worse prognoses.
Juan Alderuccio, M.D., a Sylvester hematologist and lymphoma specialist and associate professor of medicine, Miller School Related Stories"The prognosis for patients with relapsed or refractory follicular lymphoma has significantly improved over the last couple of years," he said. "We have several options, and our goal now is to keep high efficacy but also decrease toxicity. And that's what we're trying to do now."
Follicular Lymphoma Lymphoma Blood Cancer Clinical Trial Efficacy Haematology Hematology Hodgkin Lymphoma Medicine Non-Hodgkin Lymphoma Research Rituximab Tumor
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Nigel Farage claims lack of charges over Manchester Airport chaos shows 'two tier policing and two...The extraordinary footage showed a policeman violently kick and stamp on the head of a man who was face down with his hands behind his back on the floor after being tasered. In the clip, a woman could be seen watching on in horror.
Read more »
Dad-of-two suffered a sore throat - two days later he was deadThe family of well-known dad Jay Dignam say they are in complete shock
Read more »
Four miles of traffic on A1M after two-lorry crash closes two lanesLife traffic news sees traffic delays on A1M near Huntingdon after two lorries crash betweeen J15 and J14.
Read more »
Atkinson takes two wickets in two balls to leave New Zealand 125-9Follow live text updates as England face New Zealand in the second Test in Wellington.
Read more »
Dual-antibody therapy shows promise in treating metastatic colorectal cancerMetastatic colorectal cancer (mCRC) remains a daunting challenge, especially after first-line treatments fail.
Read more »
Kyushu University team develops antibody to fight age-related muscle atrophyWe all age. And while humanity's life expectancy has increased dramatically in the modern era, we still struggle with the inevitable health issues our bodies face as we get up in the years.
Read more »